Clinical trials
Phase 1 Liver Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
62 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 6 |
| 2024 | 7 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 53 |
| Recruiting | 3 |
| Terminated | 2 |
| Withdrawn | 2 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 4 |
| Celgene | 3 |
| National Cancer Institute (NCI) | 3 |
| Pfizer | 3 |
| Amgen | 2 |
| AstraZeneca | 2 |
| Bayer | 2 |
| Bristol-Myers Squibb | 2 |
| Cumberland Pharmaceuticals | 2 |
| Eli Lilly and Company | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Diseases | 62 |
| Hepatic Insufficiency | 7 |
| Liver Neoplasms | 5 |
| Lymphoma, Follicular | 5 |
| Neoplasms | 5 |
| Digestive System Diseases | 4 |
| Carcinoma, Hepatocellular | 3 |
| Hepatitis C | 3 |
| Hepatitis B | 2 |
| Non-alcoholic Fatty Liver Disease | 2 |
Trials
Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.